Joseph Edelman, 10% Owner at Lyra Therapeutics, Inc. (LYRA), sold 133,671 shares at $4.54 ($654K) on 2025-11-10, disclosed to the SEC on 2025-11-10.
Open-market sale of $654k LYRA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.18 | 3,247 | $17K | 2.6% |
| 2 | $5.18 | 28,902 | $150K | 22.9% |
| 3 | $5.18 | 28,902 | $150K | 22.9% |
| 4 | $4.75 | 1,993 | $9K | 1.4% |
| 5 | $4.75 | 17,746 | $84K | 12.9% |
| 6 | $4.75 | 17,746 |
| $84K |
| 12.9% |
| 7 | $4.54 | 1,869 | $8K | 1.3% |
| 8 | $4.54 | 16,633 | $76K | 11.5% |
| 9 | $4.54 | 16,633 | $76K | 11.5% |
| Total | $4.89 avg | 133,671 | $654K | 100% |
| Filing → |
| ALDX | BUY | 2024-04-08 | $1.7M | — | Filing → |
| ATHA | BUY | 2023-12-29 | $2.9M | — | Filing → |
| VRCA | BUY | 2023-12-29 | $4.6M | — | Filing → |